Simvastatin, an HMG-CoA Reductase Inhibitor, Reduced the Expression of Matrix Metalloproteinase-9 (Gelatinase B) in Osteoblastic Cells and HT1080 Fibrosarcoma Cells
MMP-9 or Gelatinase B, a member of the matrix metalloproteinase family (MMPs), plays important roles in physiological events such as tissue remodeling and in pathological processes that lead to destructive bone diseases, including osteoarthritis and periodontitis. In addition to its effect on the in...
Saved in:
Main Authors: | Pasutha D. Thunyakitpisal (Author), Risa Chaisuparat (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2004-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of 6-Shogaol on the Glucose Uptake and Survival of HT1080 Fibrosarcoma Cells
by: Angie C. Romero-Arias, et al.
Published: (2019) -
The Effects of HMG-CoA Reductase Inhibitor on Vascular Progenitor Cells
by: Kusuyama Takanori, et al.
Published: (2006) -
Frequency-Dependent Antioxidant Responses in HT-1080 Human Fibrosarcoma Cells Exposed to Weak Radio Frequency Fields
by: Hakki Gurhan, et al.
Published: (2024) -
QSAR Regression Models for Predicting HMG-CoA Reductase Inhibition
by: Robert Ancuceanu, et al.
Published: (2024) -
Molecular docking studies of Triphala with catalytic portion of HMG-CoA reductase enzyme
by: Prasoborn Rinthong, et al.
Published: (2023)